✦ LIBER ✦

Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs

✍ Scribed by Dumont, J. A.; Liu, T.; Low, S. C.; Zhang, X.; Kamphaus, G.; Sakorafas, P.; Fraley, C.; Drager, D.; Reidy, T.; McCue, J.

Book ID: 111891184
Publisher: American Society of Hematology
Year: 2012
Tongue: English
Weight: 286 KB
Volume: 119
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2011-08-367813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical and functional characterizat

Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein

✍ PETERS, R. T.; TOBY, G.; LU, Q.; LIU, T.; KULMAN, J. D.; LOW, S. C.; BITONTI, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

Influence of aggregation on immunogenici

Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice

✍ Vivek S. Purohit; C. Russell Middaugh; Sathyamangalam V. Balasubramanian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Recombinant human factor VIII (rFVIII), a multidomain glycoprotein is used in replacement therapy for treatment of hemophilia A. Unfortunately, 15%-30% of the treated patients develop inhibitory antibodies. The pathogenesis of antibody development is not completely understood. The presence of aggreg

Hemostatic effect of recombinant factor

Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice

✍ K. ØVLISEN; A. T. KRISTENSEN; L. A. VALENTINO; N. HAKOBYAN; J. INGERSLEV; M. TRA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Improved kinetics of rIX-FP, a recombina

Improved kinetics of rIX-FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs

✍ M. W. NOLTE; T. C. NICHOLS; J. MUELLER-COHRS; E. P. MERRICKS; I. PRAGST; S. ZOLL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

Comparative immunogenicity of recombinan

Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII

✍ E. T. Parker; H. N. Craddock; R. T. Barrow; P. Lollar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Effect of route of administration of hum

Effect of route of administration of human recombinant factor VIII on its immunogenicity in Hemophilia A mice

✍ Aaron Peng; Puneet Gaitonde; Matthew P. Kosloski; Razvan D. Miclea; Prashant Var 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Factor VIII is a multi-domain glycoprotein and is an essential cofactor in the blood coagulation cascade. Its deficiency or dysfunction causes Hemophilia A, a bleeding disorder. Replacement using exogenous recombinant Factor VIII (FVIII) is the first line of therapy for Hemophilia A. Immunogenicity,